Difference between revisions of "Hepatocyte nuclear factor-1beta"

Jump to navigation Jump to search
+PDAC
(→‎Positive: fix typo)
(+PDAC)
Line 4: Line 4:
*[[Clear cell carcinoma of the ovary]].
*[[Clear cell carcinoma of the ovary]].
*[[Renal cell carcinoma]]s - including [[clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal |authors=Hanley KZ, Cohen C, Osunkoya AO |title=Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall |journal=Appl. Immunohistochem. Mol. Morphol. |volume=25 |issue=2 |pages=134–138 |date=February 2017 |pmid=26574638 |doi=10.1097/PAI.0000000000000279 |url=}}</ref><ref name=pmid32150988>{{cite journal |authors=Kim M, Joo JW, Lee SJ, Cho YA, Park CK, Cho NH |title=Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes |journal=Cancers (Basel) |volume=12 |issue=3 |pages= |date=March 2020 |pmid=32150988 |pmc=7139472 |doi=10.3390/cancers12030602 |url=}}</ref>
*[[Renal cell carcinoma]]s - including [[clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal |authors=Hanley KZ, Cohen C, Osunkoya AO |title=Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall |journal=Appl. Immunohistochem. Mol. Morphol. |volume=25 |issue=2 |pages=134–138 |date=February 2017 |pmid=26574638 |doi=10.1097/PAI.0000000000000279 |url=}}</ref><ref name=pmid32150988>{{cite journal |authors=Kim M, Joo JW, Lee SJ, Cho YA, Park CK, Cho NH |title=Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes |journal=Cancers (Basel) |volume=12 |issue=3 |pages= |date=March 2020 |pmid=32150988 |pmc=7139472 |doi=10.3390/cancers12030602 |url=}}</ref>
*[[Pancreatic ductal adenocarcinoma]].<ref name=pmid30065837>{{cite journal |vauthors=Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M |title=Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |journal=Biomark Res |volume=6 |issue= |pages=25 |date=2018 |pmid=30065837 |pmc=6062876 |doi=10.1186/s40364-018-0139-6 |url=}}</ref>


Note:
Note:
48,466

edits

Navigation menu